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Until the advent of a live-attenuated vaccine
in the early 1960s, measles was an epidemic
disease worldwide. Today many countries have
controlled measles, but the disease remains
endemic on most continents. Development of a
live-attenuated measles vaccine and implemen-
tation of laws that required proof of vaccination
upon school entry dramatically reduced the
incidence of measles in the United States. The
number of reported cases plummeted from
approximately 500,000 before vaccine intro-
duction in 1963 to fewer than 1,500 in 1983.
Despite these measures, a reemergence or
resurgence of measles in the United States
from 1989 to 1991 resulted in more than 55,000
cases of measles and approximately 120
measles-associated deaths (Figure 1; 1). In
exploring the reasons for the resurgence, our
laboratory genetically characterized measles vi-
ruses isolated from wild-type virus-infected
persons from the same outbreak or temporally and
geographically distinct outbreaks in the United
States; in the regions examined, all measles viruses
isolated during the period of resurgence were
almost identical in nucleotide sequence and
genetically distinct from vaccine strains (2).
Measles isolates from many regions of the
world have been characterized in parallel studies
by our laboratory and by others. In conjunction
with classic epidemiologic investigations, these
well-characterized viruses have formed a picture
of the distribution of wild-type measles viruses in
most areas of the world. Eight distinct genotypes
have been identified, and undoubtedly more will
be added. Some are localized to specific regions,
while most are widely distributed. The assembly
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Wild-type measles viruses have been divided into distinct genetic groups
according to the nucleotide sequences of their hemagglutinin and nucleoprotein genes.
Most genetic groups have worldwide distribution; however, at least two of the groups
appear to have a more limited circulation. To monitor the transmission pathways of
measles virus, we observed the geographic distribution of genetic groups, as well as
changes in them in a particular region over time. We found evidence of interruption of
indigenous transmission of measles in the United States after 1993 and identified the
sources of imported virus associated with cases and outbreaks after 1993. The pattern
of measles genetic groups provided a means to describe measles outbreaks and
assess the extent of virus circulation in a given area. We expect that molecular
epidemiologic studies will become a powerful tool for evaluating strategies to control,
eliminate, and eventually eradicate measles.
Figure 1. Incidence of U.S. measles cases and measles
deaths between 1980 and 1997. Total number of
measles cases for years 1993-1997 (week 35) are
indicated above each bar.
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of these sequences into a large database, which
includes their geographic distribution, has become
a new means by which measles transmission
pathways can be traced and control measures can
be assessed. This “molecular epidemiology” has
affected the U.S. measles elimination program, and
if used appropriately with standard epidemio-
logic methods, it will affect global measles
elimination and eradication. This article summa-
rizes the status of the known measles genotype
distribution throughout the world and describes
how molecular epidemiologic information has
been used to assess the effectiveness of measles
elimination in the United States.
Global Distribution of Measles Genotypes
In most cases, genetic characterization of
wild-type measles viruses has been conducted by
sequencing the genes coding for the hemaggluti-
nin (H) protein or the nucleoprotein (N). Of the
six genes on the viral genome, the H and N genes
are the most variable. Over their protein coding
regions, the H and N genes vary by up to 7% at the
nucleotide level. The single most variable part of
the measles genome is the 450 nucleotides that
code for the COOH-terminus of the N protein,
where nucleotide variability between various
wild-type viruses can approach 12%. Several
laboratories have analyzed the sequences of wild-
type measles viruses and assigned the viruses to
various genetic groups (2-14). At present, no
widely accepted standard is available for
describing genetic groups of measles virus.
However, with a few exceptions, the assignment
of viruses to a particular group has been
consistent between laboratories (10).
Many of our studies have focused on the
genetic characterization of measles viruses
associated with cases and outbreaks in the
United States during the last 10 years (2,11).
These viruses can be separated into at least eight
distinct genetic groups (Table; Figure 2).
Phylogenetic analyses using various computer
programs (15-17) indicated good statistical
support for each of the groups described below.
Actually, more than eight genetic groups are
listed when viruses from groups not yet found in
the United States are included (e.g., Zambia:
1993, Germany: 1992) (Figure 2). The number of
genetic groups is likely to increase since the true
extent of genetic heterogeneity among wild-type
measles viruses is still unknown, and virologic
surveillance has not been conducted or has only
just begun in many areas of the world.
Group 1 contains the prototype, Edmonston
strain, which was isolated in 1954. This group
also contains all vaccine viruses sequenced
regardless of whether they were derived from
Edmonston (Attenuvax, Edmonston-Zagreb,
AIKC, Schwarz) or from temporally and
geographically independent wild-type isolates
(Shanghai-191: China, Changchun-47: China,
CAM-70: Japan, Leningrad-16: Russia) (18).
Relatively few wild-type viruses from the
prevaccine era are available for molecular
characterization. These viruses, which were
isolated in Japan, Russia, Finland, Romania, and
the United States during the 1950s and 1960s,
are in group 1 (9). Therefore, while viruses
belonging to the other genetic groups may have
been present, group 1 viruses must have had
widespread distribution during the prevaccine
era. Group 1 viruses continue to circulate, and
viruses from group 1 were isolated from patients
with clinical measles in the United States, United
Kingdom, Russia, China, and Argentina during
the last 7 years (5,11,19,20, and unpub.
observations). These recent group 1 wild-type
Table. Sources of genotypes isolated in the United
States, 1995–1997
No. of Imports Also
Group isolates from circulating in
4 13 Germany, Spain, Central Europe,
  United Kingdom,   Canada,
  Brazil, Austria,   Brazil, United
  Italy, Greece,   Kingdom
  Ukraine
3   9 Japan Japan, Thailand
5   8 Italy, Germany Central Europe,
  United King-
   dom, Brazil
7   3 Pakistan, Kenya South Africa,
  Canada
8   2 China, Vietnam China
2   1 Philippines United States
  1989–1992,
  Micronesia
1   1 Unknown United King-
  dom, Russia,
  China,
  Argentina
6   1 Kenya The Gambia,
  Cameroon,
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viruses have several nucleotide substitutions
that distinguish them from vaccine viruses. In
contrast, measles vaccine viruses reisolated from
immunosuppressed patients with giant cell
pneumonia had nucleotide sequences nearly
identical to those of the vaccine virus found in the
vaccine vial (unpub. observations). This suggests
that vaccine viruses are very stable even after
prolonged replication in a human host. There-
fore, it is unlikely that the group 1 wild-type
viruses represent laboratory contamination of
cultures with vaccine virus or reisolation of
vaccine virus from recently vaccinated persons.
Sequence studies have failed to identify a distinct
set of genetic markers that consistently differenti-
ate wild-type and presumably virulent viruses from
attenuated viruses. Current studies are focusing on
the analysis of the noncoding regions of the viral
genome. More studies are needed to compare
attenuated strains with their more virulent or
reactogenic precursors. The recent development of
an infectious clone for measles (21) will, no doubt,
contribute to those studies.
Group 2 viruses were associated with the
resurgence of measles in the United States
between 1989 to 1991, an epidemic that had an
unusually high incidence of deaths and hospital-
izations (Figure 1). The circulation of group 2
viruses within the United States was interrupted
in 1993, and this will be described in more
detail below. Among these viruses, the Illinois-1
(Chicago-1) strain has become a representative of
recent wild-type viruses, and almost the entire
genome has been sequenced. Group 2 viruses were
first isolated in Japan during the early 1980s; more
recently, they were isolated in Japan, the
Philippines, and Micronesia (2,11-13,22).
The group referred to as group 3 viruses can
actually be divided into two distinct groups with a
common geographic distribution. These viruses
have been isolated from outbreaks in Japan and
Thailand and from sporadic cases following
importation into North America and Europe
(2,11). Although virus from groups 2 and 3
cocirculated in Japan during the late 1980s and
early 1990s, the group 3 viruses have recently
become the predominant genotype (23).
Groups 4 and 5 appear to be circulating
widely in many countries in western Europe,
particularly Germany, Spain, and the United
Kingdom, where virologic surveillance has been
conducted (6,7,24). Viruses from this group are
also circulating in France, Italy, Austria, and
Greece since they have been associated with
multiple importations from these areas into the
United States (2,11; Table).
All representatives of the group 6 viruses
have been isolated in the African countries of The
Gambia (4), Cameroon, Gabon, and Zambia or
associated with importations into the United
States from Kenya. There is more genetic
variability within the group 6 viruses than among
most of the other genetic groups, yet all group 6
viruses contain a subset of nucleotide substitu-
tions that places them on this African lineage.
Figure 2. Phylogenetic tree showing genetic relation-
ships between the eight genetic groups of measles
virus associated with U.S. outbreaks and cases since
1988. The location and year of isolation is given for
each virus. Viruses not assigned to one of the eight
groups are labeled in brown. The unrooted tree is
based on the sequence of the protein coding region of
the H gene (1854 nt). Wt-Edmonston = low passage
seed of the original Edmonston isolate. SSPE =
sequences obtained from cases of subacute sclerosing
panencephalitis.32 Emerging Infectious Diseases Vol. 4, No. 1, January–March 1998
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Relatively few viruses from central Africa, where
most measles infections are occurring, have been
isolated for genetic analysis, and it will be
interesting to determine if other genotypes are
also present in this area.
Group 7 viruses were first isolated during an
epidemic in Montreal, Canada, in 1988 (2,11).
Group 7 was the predominant group among a
number of recently isolated viruses from
Johannesburg, South Africa (9,25,26). The identifi-
cation of a group 7 virus in association with an
importation to the United States from Pakistan
suggests (11) that the viruses in this group may be
circulating widely in Africa and Asia.
The group 8 viruses form a highly distinct
group isolated in four provinces within the
People’s Republic of China during the early 1990s
(19). Like group 6, group 8 viruses have more
nucleotide variability within the group (up to 3%)
than the other groups. Recent evidence also
suggests that group 8 viruses are circulating in
other parts of China (Hong Kong) and in Vietnam.
Several recently isolated viruses do not fit
into the eight genetic groups that, so far, contain
most recent isolates (Figure 2). Some outliers
represent single isolations of a unique genetic
type. However, preliminary analysis of a number
of wild-type viruses from Zambia indicates that
these viruses belong to a genetic group that is
distinct from the eight groups described thus far
(unpub. observations).
If viruses isolated during the early to mid-
1980s were included into the genetic analysis (not
shown), it would be apparent that more genetic
groups exist. However, viruses representing
these groups have not been isolated in the last 10
to 15 years, and it must be assumed that these
groups are circulating in restricted geographic
regions, are circulating at such a low frequency as
to escape surveillance, or are extinct.
A summary of genetic groups (Figure 3)
represents a static picture that simply identifies
where particular genetic groups have been
isolated, with no accounting for frequency of
isolation or source of the virus. Certain regions of
the world (including much of Africa and most of
southern Asia) are still vastly underrepresented. A
survey of recent Australian isolates is in progress.
The pattern of genotypes in the United Kingdom
and the United States is very complex because of
relatively good strain surveillance and the
frequency of international travel to these locations.
Molecular Epidemiology
Measles has long been considered one of the
most communicable of diseases. The resurgence
of disease from 1989 to 1991 in the United States
(Figure 1) provides a good example of the rapid
transmissibility of the virus. During this
resurgence only group 2 viruses were isolated,
and the sequences from these viruses were highly
related (2). With continued molecular surveil-
lance, we were able to document the interruption
of transmission of the group 2 viruses and
monitor the change in measles genotypes
associated with outbreaks and sporadic cases
from 1994 to the present. Molecular surveillance
of measles viruses was most useful when the
change in genotypes was observed over time.
Without that information, it would not have been
possible to describe the transition from an
apparently “indigenous” lineage to importation of
multiple lineages (Figure 4). This is in contrast to
the situation in South and Central America. In
these areas, viral surveillance was not conducted
before mass vaccination campaigns were initiated,
so the identity of the prevailing genotype could not
be determined. Therefore, it is difficult to interpret
the genetic data obtained from viruses currently
causing outbreaks in these regions.
The molecular surveillance of wild-type
viruses in the United States between 1989 and
Key to genotypes:
Group 3 Group 4 Group 2
Group 5 Group 6
Group 1
Group 7 Group 8
Americas, 1988-1997 Europe and Asia, 1988-1997
Figure 3. Global distribution of measles genetic
groups. Colored circles indicate areas where measles
viruses from various genetic groups have been
isolated. Viruses not assigned to one of the eight
groups are labeled in brown.33 Vol. 4, No. 1, January–March 1998 Emerging Infectious Diseases
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1997 provides the best example of dynamic
molecular surveillance (Figure 4). Viruses
isolated over a 4-year period from major
outbreaks in New York, Philadelphia, Chicago,
Los Angeles, Houston, and southern Texas varied
by less than 0.4% at the nucleotide level in the H
and N genes (2). Analysis of the few wild-type
measles viruses isolated in the United States
before 1988 indicates lineages other than group 2.
This suggests that the group 2 viruses were
probably imported during the late 1980s and
were rapidly transmitted to the entire country.
While numerous importations occurred during
the resurgence, apparently these viruses did not
circulate widely enough to be detected by
molecular surveillance. Perhaps the number of
measles-susceptible persons in the U.S. popu-
lation during the resurgence was high enough
to sustain continuous transmission without
accumulation of variants or displacement by
other imported viruses.
More aggressive childhood vaccination pro-
grams, the introduction of a two-dose schedule,
and successful mass vaccination campaigns
conducted by the Pan American Health Organi-
zation in South and Central America greatly
reduced the number of reported measles cases in
the United States in 1993 (Figure 1). During a 6-
week period at the end of 1993, no indigenous
cases of measles were reported (27). Molecular
surveillance of measles viruses associated with
cases and outbreaks in the United States during
1994, 1995, 1996, and 1997 documented this
interruption of transmission of what had been the
indigenous genotype (2,11). Only one group 2
virus was detected in the United States after
1993, and this was directly linked to importation
from the Philippines (11).
Molecular surveillance data allow us to draw
several conclusions about the transmission of
measles virus in the United States. The first is
that increasing the level of population immunity
by vaccination can interrupt the transmission of
measles virus. This is hardly new information,
and interruption of transmission was described
for The Gambia in 1983 and more recently in
Figure 4. Change in genetic groups of measles viruses associated with U.S. cases and outbreaks between 1988 and
September 1997. Arrows indicate sources of virus, if known.34 Emerging Infectious Diseases Vol. 4, No. 1, January–March 1998
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Finland. However, our studies are the first in
which genetic analysis of measles strains has
been used to document interruption of
transmission. Secondly, long-term asymptom-
atic transmission of virus is unlikely since no
group 2 viruses were detected in the United
States after 1993 that were not directly linked
to importation. Finally, measles will not be
fully controlled anywhere until it is controlled
globally. Virus introduced by importation will
continue to fuel sporadic outbreaks and
epidemics even in areas with relatively good
control measures. These observations should
strengthen our resolve to accelerate measles
control activities on a global level.
The molecular data imply that under
conditions of continuous indigenous transmission
of measles virus, the number of circulating
genotypes is limited. As population immunity
increases, the pattern of genotypes becomes more
complex to reflect the multiple sources of
imported virus. We hope to test this model
further by conducting molecular surveillance of
wild-type measles viruses circulating in areas
that still have endemic measles.
Conclusions
Genetic characterization of wild-type measles
viruses provides a valuable means to measure the
level of virus circulation in areas just beginning
to implement measles control plans. In areas that
already achieved good measles control, molecular
epidemiologic studies provide a means to
describe outbreaks and cases. Identifying the
source of the virus can lead to improved control
measures. To be maximally effective, molecular
epidemiologic studies must include surveys of
viral genetic groups from all areas of the world.
Specimens for viral isolations should be obtained
from as many chains of transmission as possible.
Obtaining specimens must become an integral
part of measles surveillance and be included in
the standard operating procedures for investigat-
ing measles cases. If we can establish a large
database to describe the indigenous genetic
groups before large-scale control measures are
enacted, we can closely monitor the ability of
these control measures to reduce or interrupt
transmission of measles. Molecular epidemiology
will greatly enhance measles elimination and
eradication efforts.
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